We have conducted a study to assess whether daily ingestion of sulforaphane by COPD patients for four weeks increased Nrf2 activity in alveolar macrophages and bronchial epithelial cells. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.